Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The immunocompromised patient and transfusion.

× No keyword cloud information.

49 in total

1. Generation of cytokines in red cell concentrates during storage is prevented by prestorage white cell reduction.

Authors: A Shanwell; M Kristiansson; M Remberger; O Ringdén
Journal: Transfusion Date: 1997-07 Impact factor: 3.157

2. Quality of blood components filtered before storage and at the beside: implications for transfusion practice.

Authors: M A Popovsky
Journal: Transfusion Date: 1996-05 Impact factor: 3.157

3. The presence of free infectious cytomegalovirus (CMV) in the plasma of donated CMV-seropositive blood and platelets.

Authors: D J James; S Sikotra; M Sivakumaran; J K Wood; J A Revill; V Bullen; S Myint
Journal: Transfus Med Date: 1997-06 Impact factor: 2.019

Review 4. The mechanisms of leukocyte removal by filtration.

Authors: A Bruil; T Beugeling; J Feijen; W G van Aken
Journal: Transfus Med Rev Date: 1995-04

Review 5. The role of leukodepletion in the control of transfusion-transmitted disease.

Authors: M Goldman; G Delage
Journal: Transfus Med Rev Date: 1995-01

6. Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled clinical trials.

Authors: E C Vamvakas
Journal: Transfusion Date: 1996-02 Impact factor: 3.157

Review 7. Human parvoviruses: implications for transfusion medicine.

Authors: N L Luban
Journal: Transfusion Date: 1994-09 Impact factor: 3.157

Review 8. Methods for the reduction of transfusion-transmitted cytomegalovirus infection: filtration versus the use of seronegative donor units.

Authors: C D Hillyer; R K Emmens; M Zago-Novaretti; E M Berkman
Journal: Transfusion Date: 1994-10 Impact factor: 3.157

9. Hypotensive reactions to white cell-reduced plasma in a patient undergoing angiotensin-converting enzyme inhibitor therapy.

Authors: M R Fried; T Eastlund; B Christie; G T Mullin; N S Key
Journal: Transfusion Date: 1996-10 Impact factor: 3.157

Review 10. Posttransfusion graft-versus-host disease in Japanese newborns.

Authors: H Ohto; K C Anderson
Journal: Transfusion Date: 1996-02 Impact factor: 3.157

3 in total

1. Seroprevalence of Cytomegalovirus among Voluntary Blood Donors.

Authors: C N Chaudhari; M S Bindra
Journal: Med J Armed Forces India Date: 2011-07-21

2. Perioperative blood usage and therapeutic plasma exchange in kidney transplantation during a 16-year period in South Korea.

Authors: Banseok Kim; Minjin Kang; Jae Kwang Lee; Hyung Soon Lee; Yongjung Park
Journal: Blood Transfus Date: 2020-06-10 Impact factor: 3.443

Review 3. Cytomegalovirus and Epstein-Barr Infections: Prevalence and Impact on Patients with Hematological Diseases.

Authors: Jean de Melo Silva; Renato Pinheiro-Silva; Anamika Dhyani; Gemilson Soares Pontes
Journal: Biomed Res Int Date: 2020-10-24 Impact factor: 3.411

3 in total